This study has shown that T lymphocytes with αβ TCR present in normal human skin possess unique characteristics which may allow them to fulfil a unique role in skin. It disclosed that unlike T cells from blood, they are devoid of proliferative capacity in response to any ligand including lectins and phorbol esters, and show a diminished Ca 2⍣ flux in response to phytohemagglutinin (PHA). However, despite this apparent lack of reactivity, these cells respond to stimulation by synthesis of IFN-γ. These observations suggest that this pre-formed mRNA may be solely responsible for the early synthesis of IFN-γ in skin, determining both the amount and the duration of its synthesis. We propose that these cells may represent the antigen-specific component of a first-line host defence system in human skin. The reported absence of delayed-type hypersensitivity reactivity in patients with a selective deficit of skin T cells supports this conclusion.
Introduction
In 1983 Streilein proposed the existence of skin-associated lymphoid tissues or SALT, constituting a functional unit to provide the skin with a unique immune system (1). This proposal was based in part on the concept of immune surveillance against tumors first proposed by Thomas (2) , amplified by Burnet (3) and focused on the skin by Mitchison and Kinlen (4) . Observations of a high incidence of cutaneous malignancies in chronically immunosupressed organ transplant recipients suggested that in healthy individuals tumor incidence may be prevented by a skin-based immune system. Evidence obtained by Macher and Chase (5) and extensive data from murine systems of contact hypersensitivity by Streilein's group provided complementary evidence to show Correspondence to: J. Gordon, 4130 Trafalgar Road, Montreal, Quebec H3Y 1R2, Canada
Transmitting editor: H. Wigzell Received 14 February 1998, accepted 13 July 1998 that immunization via the skin was particularly efficient. This was attributed to the demonstrated ability of keratinocytes to produce ETAF (6) or IL-1, later extended to other inflammatory cytokines also produced and stored by mast cells (7) . In addition, the skin was known to have a unique, highly efficient antigen-presenting cell (APC), the Langerhans cell. While T, but not B lymphocytes were shown to be present in skin (8) , their role in immune responses initiated via the skin was less clear. The concept questioned here is that of 'peripheral sensitization'. Streilein suggested that lymphocytes responded to antigen within the skin, but he could not rule out the possibility that the ones activated following cutaneous administration of antigen were those present in lymph nodes draining the skin and not the ones present in the skin. The latter alternative gained support by the repeatedly demonstrated ability of Langerhans cells to leave the skin, transporting antigen to the lymph node and initiate lymphocyte activation there (9, 10) . However, subsequent observations made in rodents and ruminants rehabilitated the skin lymphocytes, the large majority of which were shown to be γδ T cells (11, 12) . Janeway et al. suggested that γδ T cells prominent also in the gut may have the special function of providing immune protection of epithelial surfaces (13) . This view was in accord with data showing the efficient recirculation of memory γδ T cells between skin and blood, essentially excluded from other secondary lymphoid organs (12) . However, surprisingly this pattern was not shared with humans. Thus, with the exception of the gut, γδ T cells were not prominent in any lymphoid tissue including the skin (14) , where they were largely absent (15) .
Another observation made in humans turned out to be more fruitful. Based on the unique propensity of cutaneous, but of no other form of lymphomas to localize in skin (16) , Streilein (1) suggested that a subset of normal T cells may share this property and be part of the skin immune system. Indeed, in a series of elegant studies Picker et al. have identified a subset of T cells in the circulation which carried a so-called cutaneous lymphocyte antigen (CLA) on their surface (17) . This property was shared with cutaneous, but no other form of lymphomas (18) , with lymphocytes infiltrating cutaneous delayed-type hypersensitivity (DTH) reactions (19) and lymphocytes present in normal human skin (20) . Based on the observation that the CLA molecule itself was shown to have properties of adhesion molecules with affinity for Eselectin preferentially expressed on inflamed skin vascular epithelium (21, 22) , Picker et al. (19) suggested that these cells may recirculate between skin and blood, which are their richest source, and thus might be part of the skin immune system.
The present study was prompted by the foregoing considerations, as well as being triggered by a project pursued in our laboratory for over 20 years (23) . The latter appeared to have identified a group of patients deficient in lymphocytes solely in their skin, who lacked DTH reactivity and had a lifethreatening immune deficit (24) . To validate our observations and the concept of the skin immune system, and to look for evidence in support of a role of T cells present in skin, we undertook to study the phenotypic and functional properties of lymphocytes isolated from human skin.
Methods

Cell purification
Facial skin from cosmetic surgery was collected in HBSS containing 2% FCS on ice. Further processing using sterile conditions, initiated within 2 h, were also performed on ice. Subcutaneous fat was removed with a scalpel and spots of skin with blood were also eliminated. Cleaned pieces of skin were chopped into small fragments with scissors and 2 g portions were transferred into 50 ml Erlenmayer flasks with 20 ml extraction medium. The latter consisted of 1.5 mg/ml collagenase (L-type), 0.75 mg/ml hyaluronidase (both from Sigma, Mississauga, Ontario, Canada), 35 mg/ml BSA, 0.1% DNase I (both from Boehringer Mannheim, Laval, Quebec, Canada) dissolved in RPMI 1640 medium supplemented with 10% FCS (Gibco/BRL, Burlington, Ontario, Canada), 2 mM Lglutamine, (Gibco/BRL), 20 µg/ml gentamycin (Sigma), 2.5 µg/ml fungizone (Gibco/BRL), 100 U/ml penicillin and 100 mg/ml streptomycin (Gibco/BRL). The skin preparations were incubated overnight (18 h) on an orbital shaker (Bellco Biotechnology, Vineland, NY) at a sufficient speed to keep the skin fragments in suspension. Following this extraction leaving small translucent fragments of skin behind, the cells in suspension were collected over a sieve, centrifuged and washed twice with HBSS/2% FCS. The lymphocytes recovered were enriched either by filtration through nylon wool (NW) (Baxter, Pointe Claire, Quebec, Canada) or by gradient centrifugation in Percoll (Pharmacia, Baie d'Urfe, Quebec, Canada). In the former procedure 1.3 g of autoclaved NW prewetted with HBSS was packed into a 10 ml syringe and equilibrated with RPMI 1640/10% FCS for 1 h at 37°C. The 3ϫ10 7 cells in 1 ml complete medium prewarmed to 37°C were run into a column and incubated for 45 min. Non-adherent cells eluted with the same medium were collected by centrifugation and were washed with HBSS containing 10% human AB serum (Red Cross, Montreal, Quebec, Canada).
For purification on Percoll 2ϫ10 7 skin cells were pelleted and suspended in 2 ml of 90% Percoll solution, prepared by dilution with Ca 2ϩ and Mg 2ϩ -free PBS containing 0.01% EDTA and 0.9% NaCl. The cells in the 90% solution of Percoll were successively overlaid in 3 ml Percoll at 70, 45 and 30% concentration diluted with PBS containing 0.01 M EDTA. Sedimentation of the skin cells to equilibrium was achieved by centrifugation at room temperature for 20 min at 617 g. Each fraction was collected, washed to remove Percoll, suspended in a small volume of complete medium, counted with Trypan blue and later analyzed by FACS. The cells harvested from the 30% layer were mostly epithelial and contained dead cells. Fully viable lymphocytes were recovered from both the 45 and 70% Percoll interface. Since the latter yielded 2-4 times more lymphocytes and usually in a higher state of purity, these cells were used in most experiments. The yield of lymphocytes per gram of skin from NW ranged from 0.1-0.3ϫ10 6 , while that from the Percoll procedure was 0.2-1.3ϫ10 6 . Their purity from cell counts, verified by flow cytometry, ranged from 65 to 86%.
Dendritic cells from skin were prepared following the method of Nestle et al. (25) . Briefly, skin freed from subcutaneous fat was incubated with Dispase type 2 (BoehringerMannheim) for 1 h at 37°C at an enzyme concentration of 1.2 U/ml, dissolved in RPMI 1640. Following this incubation, which allowed teasing apart dermis from epidermis, both tissues were minced and incubated for 3 days in complete medium (CM) in plastic Petri dishes to allow release of non-adherent cells into the supernatant solution. CM consisted of 10% human AB serum, L-glutamine (2 mM), penicillin (100 U/ml), streptomycin (100 µg/ml) and Fungizone (2.5 µg/ml). In two such preparations, 4.6 g of skin in experiment 1 and 2 g in experiment 2 yielded 4.2ϫ10 6 and 0.9ϫ10 6 cells from dermis and epidermis for experiment 1 and 1.8ϫ10 6 and 0.4ϫ10 6 for experiment 2 respectively. All the cells recovered were viable by Trypan blue exclusion. In both preparations large cells with a dendritic morphology stained with anti-HLA-DR were identified. Their frequency (reported as 20-30% by Nestle et al.) was not established in our experiments. We used these preparations as a source of dermal and epidermal dendritic cell APC after 3000 rad of γ irradiation.
Peripheral blood mononuclear cells (PBMC) were prepared from either defibrinated or heparinized blood by centrifugation on Hypaque-Ficoll (Pharmacia, Montreal, Quebec, Canada). These cells were used as a source of APC for autochtonous skin cells following irradiation (3000 rad).
Depletion of APC from PBMC was performed by magnetic separation (Dynal, Lake Success, NY). Cells (1.5ϫ10 7 ) in 3 ml FACS buffer (0.1% BSA in PBS, pH 7.4) were mixed with 7.5 µg of an anti HLA-DR and 30 µg of an anti CD14 mAb (both obtained from Becton Dickinson, Mountain View, CA) and incubated for 30 min at 4°C with rotation. Following two washes, 1.5ϫ10 7 magnetic beads coated with a sheep antimouse IgG were added in 1 ml FACS buffer and incubated for 30 min at 4°C. HLA-DR -cells (6.9ϫ10 6 ) were recovered following the removal of antibody-coated cells on a magnet.
Flow cytometry
In most experiments skin lymphocytes (3-10ϫ10 6 ) and peripheral blood lymphocytes (PBL) from the same donor were analysed in parallel to collect 5-15,000 events for single-and three-color analysis in a FACScan (Becton Dickinson). All primary and secondary antibodies were pretitrated and used at optimal concentration. Controls for primary antibodies were normal Ig of the same isotype used at the same protein concentration as the test antibody; controls for biotinylated antibodies were normal Ig biotinylated. The following reagents were used. Anti-CD4-phycoerythrin (PE), anti-CD8-PE and anti-CD45RO-PE from Sigma (St Louis, MO). Anti-CD45RA from PharMingen (San Diego, CA). Anti-CD29-PE from (Coulter Immunology, Hialeah, FL). Anti-CD3-PERCP, anti-HLA-DR and anti-CD25-FITC from Becton Dickinson (San Jose, CA). Anti-VLA-α 4 (B5G10) from Dr M. Hemler (Dana Farber Cancer Institute, Boston, MA). Anti-VLA-α 4 (P4G9) from Gibco. Anti-VLA-α 4 , (44H6) purified from culture supernatant and biotinylated in our laboratory, from Dr M. Letarte (Hospital for Sick Children, Toronto). Anti-CLA (HECA-452) from Dr J. L. Picker (University of Texas Southwestern Medical Center, Dallas). Purified Ig of different isotypes unlabeled or conjugated with PE or FITC from Caltag (San Francisco, CA). Goat anti-rat IgM-FITC from Jackson Immunoresearch (Westgrove, PA). Streptavidin-PE from Southern Biotechnology Associates (Birmingham, AL). Labeling was performed in 96-well Vbottom plates cooled on ice. Cells were washed 2 times with FACS buffer (PBS with 0.1% BSA and 0.02% sodium azide, pH 7.4), then incubated with the primary antibodies in a volume of 50 µl for 30 min at 4°C. After two washes secondary isotype-specific antibodies were added and the cells incubated for a further 30 min and washed twice followed by blocking with a 1:10 diluted normal mouse serum for 10 min at room temperature. The cells spun down were further incubated with a second primary antibody directly labeled with a second fluorochrome (or with biotin) differing in isotype or species from the first primary antibody used. After 30 min of incubation and washes, followed by a last incubation with avidin-PE, the cells were washed again and fixed in 0.5% paraformaldehyde, transferred to tubes, and kept in the dark at 4°C until analysis. Analysis in most instances was performed by gating on cells in the small lymphocyte region (by forward and side scatter) or by gating on CD3 ϩ cells, or both.
(Ca 2ϩ ) i flux assay Equal numbers of blood or skin T cells were loaded with 2 µg/ml Indo-1-AM (Molecular Probes, Eugene OR) in 1 ml of Hanks solution without phenol red but containing 1% FCS. After 30 min incubation at 37°C, the cells were washed twice. The cell number (1-2ϫ10 6 /sample) was verified after the last wash. The cells were then resuspended in 2 ml Hanks without phenol red but with 1.3 mM Ca 2ϩ . The (Ca 2ϩ ) i flux was performed at 37°C in a fluorometer (Photon Technology, South Brunswick, NJ). The excitation wavelength was 355 nm and the emissions were monitored at 405 and 485 nm. The cells were stimulated with 10 µg/ml phytohemagglutinin (PHA) (final concentration). After the stimulation, the indole-1 loading was verified by treating the cells with 5 µg/ml ionomycin (final concentration). Finally, the cells were lysed by 0.05% Triton and Ca 2ϩ was chelated by 5 mM EGTA at pH 9.6. The data are expressed as ratios of emission at 405/480 nm during a time course of 10 min.
T cell proliferation assay Lymphocytes (2.5ϫ10 4 ) from skin or blood were cultured in 96-well round-bottom tissue culture plates in a total volume of 0.2 ml of CM. (In some experiments using PBL, penicillin, streptomycin and Fungizone were omitted from CM). Responding cells from skin (2.5ϫ10 4 ) were supplemented unless otherwise indicated with 10% irradiated (3000 rad) autochtonous PBMC as a source of APC. PHA (10 µg/ml), concanavalin A (Con A; 3.3 µg/ml), phorbol myristate acetate (PMA; 10 ng/ml) and 12-O-tetradecanoyl phorbol-13 acetate (TPA; 5 ng/ml) plus ionomycin (0.5 mM), all from Sigma, anti-CD3 (OKT3) Ϯ I L-2 (20 U/ml, R & D Systems, Minneapolis, MN) were used for stimulation. The anti-CD3 used was immobilized by precoating wells at a concentration of 2.25 µg in 50 µl of bicarbonate buffer at pH 9 overnight. Cultures with lectins and phorbol esters were incubated for 3 days; others were carried for 6 days. [ 3 H]Thymidine (1 µCi/well, sp. act. 2 Ci/mM; New England Nuclear, Boston MA) was added for the last 18 h of culture. The cultures were harvested onto glass microfiber filter strips and radioactivity was measured in a liquid scintillation counter.
Activation of lymphocytes to elicit IFN-γ production Either 0.5ϫ10 6 skin lymphocytes or 1ϫ10 6 PBL were cultured at a concentration of 1ϫ10 6 cells/ml in complete medium supplemented with 10 µg/ml PHA and 10 U/ml rIL-12, or with immobilized anti-CD3 in the presence of IL-2 as used for the proliferative response. Lymphocytes from skin were supplemented with 10% γ-irradiated autochtonous PBMC or skinderived APC. Unless otherwise indicated, cultures of skin T cells were terminated after 2.5 h of activation; PBMC were cultured for 42 h.
Detection of intracellular IFN-γ and simultaneous staining for cell surface markers The method used was that described by Sander et al. (26) with minor modifications. Briefly, cells harvested from culture were washed and transferred to microtubes where they were fixed by the addition of a solution of 4% paraformaldehyde in phosphate buffered saline, pH 7.4, for 10 min. These cells were washed and then permeabilized in a solution of 0.1% saponin in PBS/0.01% HEPES. Saponin was present throughout the subsequent staining procedure. The cells were incubated with either the anti-IFN-γ mAb D9D10 (1.5 µg/ml, at room temperature for 45 min) (27) or in control preparations with an equal concentration of normal mouse IgG of the same isotype (IgG1). After washing, the cells were counter-stained with either an FITC-labeled or a Cy-3-labeled anti-mouse IgG1 antibody. The stained cells were washed and resuspended in 20 µl of 0.1 M sodium citrate, transferred to slides, air dried and mounted with bicarbonate-buffered glycerol (1:1) containing 2% 1,4-diazobicyclo-2,2-octane to reduce fading. Surface labeling of cells when performed was done prior to fixation. The antibodies used were biotinylated anti-CD3 (1 µg/10 6 cells; PharMingen), anti-CD4, (1 µg/10 6 cells; Sigma) and anti-CD8 (OKT-8 purified from hybridoma supernatant on an anti-IgG column and biotinylated, 7 µg/10 6 cells). The labeled cells were finally exposed to streptavidin-Cy-3, 1 µg/10 6 cells, (Caltag, San Francisco, CA). The antibody pairs used for each preparation were selected to provide different fluorochromes for the cell surface or the intracellular label, distinguished by appropriate filters. Analysis and photography were performed using a Zeiss microscope (D-7082). For each preparation two counts were performed. Initially the percentage of IFN-γ-containing cells was established by examining the first 3-500 cells enumerating those with or without intracellular fluorescence. For the second analysis the smear was screened to locate every cell positive for intracellular IFN-γ (Ͼ100 cells per slide) and each inspected for surface label with the second antibody used.
IFN-γ production in skin
In order to verify the tempo of IFN-γ synthesis in skin which has not been exposed to the extraction procedure with collagenase, fresh pieces of skin stripped of subcutaneous fat were injected intracutaneously with 0.1 ml culture medium containing 10% AB serum or with medium supplemented with serum, PHA (10 µg/ml) and IL-12 (100 U/ml). Pieces of skin surrounding each injection site (~1 cm diameter) were excised and each placed in a well of a 24-well tissue culture plate with medium alone or with medium ϩ PHA ϩ IL-12 matching the injection protocol. Tissues were incubated for either 2.5 or 4 h when they were placed in OCT compound and snapfrozen; they were placed in precooled isopentane and stored at -80°C. Parallel sections from each skin preparation were stained with an antibody to CD3 (1:50 dilution; Dako, Carpinteria, CA), to IFN-γ 1.5 µg/ml (mAb D9D10 used for the isolated T cells) or a control normal IgG1. After three washes of 10 min each by immersion in Tris buffer, two drops of the second antibody used (anti-IgG1-FITC, 1/1000 dilution) (Tago, Biosource International, Montreal, Canada) were applied to the sections for 30 min followed by four washes and mounting.
RNA extraction and analysis by RT-PCR
RNA was extracted by homogenization of freshly snap-frozen whole skin or dispersion of cell suspensions in guanidine thiocyanate and centrifugation through cesium chloride (or occasionally in TRIzol reagent; Gibco/BRL, Grand Island, NY). cDNA was prepared by reverse transcriptase then amplified through 30-45 cycles of PCR in the presence of different oligonucleotide primers, all according to Dallman et al. (28) . In preliminary experiments conditions for PCR with each set of primers were optimized to yield a single product of the expected molecular size. The identity of each PCR product (except cDNA for CD25) was further ascertained by verifying that each would hybridize only with the internal oligonucleotide corresponding with the pair of primers used for amplification. The composition of the five pairs of primers used and their corresponding internal oligonucleotide were as follows. For IL-2 (29) sense primer 5Ј-ACTCACCAGGATGCTCACAT-3, antisense 5Ј-AGGTAATCCATCTGTTCAGA-3Ј and internal oligonucleotide TAAGACCCAGGGACTTA. For IFN-γ sense primer 5Ј-AGTTATATCTTGGCTTTTCA-3Ј, antisense 5Ј-ACC-GAATAATTAGTCAGCTT-3Ј and internal oligonucleotide TGC-AGAGCCAAATTGTC. For β-actin sense primer 5Ј-GGCAT-CCTCACCCTGAAGTA-3Ј, antisense 5Ј-ATTGCCAATGGTG-ATGACCTG-3Ј and internal oligonucleotide ATGGACTCCGG-TGACGG. For CD3 sense primer 5Ј-CTGGACCTGGGAAAC-GCATC-3Ј, antisense 5Ј-GTACTGAGCATCATCTCGATC-3Ј, internal oligonucleotide GTGGCTGGCATCATTGT. For CD25 sense primer 5Ј-CCATGTTGAACTGTGAATGC-3Ј, antisense 5Ј-CTGTGTAGGGCCCTGTATCC-3Ј, and internal oligonucleotide CCTGAAGAACAGAAAGA.
In additional experiments it was ascertained that plateau conditions were not reached through 45 cycles of PCR amplification. This was done by performing a semiquantitative PCR using [α-32 P]dCTP in the reaction mixture according to Leung et al. (30) . These experiments detected a linear increase in [ 32 P]dCTP incorporated following 30-45 cycles of PCR amplification as reported previously (24) . In the experiments described in the present communication cDNA generated from 0.7-2 µg RNA was amplified in RT-PCR with primers for IFN-γ, IL-2 and CD25, and 1/10 of that amount (0.07 µg) of RNA was utilized with primers for β-actin. Following PCR, analysis was by electrophoresis in agarose gel containing ethidium bromide, using an image analyser (UC12260 Scanner; Umax Data System, Fremont, CA) to compare the relative concentration of PCR products obtained within each experiment. Using this procedure (RT-PCR) positive identification of a PCR product amplified with a set of specific oligonucleotide primers signals the presence of mRNA of the same specificity in the tissues or cells extracted, in a concentration which is related to that of the cDNA amplified during PCR. For the sake of ease and clarity the PCR product obtained throughout this investigation is referred to sometimes as the cDNA amplified or as the corresponding mRNA at their source.
Results
The phenotype of skin-derived T cells
To perform functional analysis of lymphocytes from skin, it is important to rule out their contamination by lymphocytes from blood. It is equally important to show that the extraction procedures employed using enzymes did not modify their properties. To meet the first requirement, in initial experiments crude skin cell preparations obtained by digestion with collagenase were analysed by flow cytometry. The presence of both CD4 ϩ and CD8 ϩ T cells was established in the absence of detectable B lymphocytes. The absence of B cells, confirmed using lymphocytes enriched by separation on Percoll, was taken as an indication that these preparations were essentially free of blood cells. In all subsequent experiments T cells from skin were enriched by filtration through NW or flotation through Percoll gradients. The average number of lymphocytes obtained per gram of skin in 13 experiments following passage through NW was 0.1-0.2ϫ10 6 . Following centrifugation on Percoll the average yield was 0.2-1.3ϫ10 6 from 18 experiments. The lymphocyte content of these preparations from cell counts verified by flow cytometry ranged from 65 to 85%. Figure 1 shows a typical preparation: gating on the lymphocyte cluster (Fig. 1a) , 94% of the cells were labeled with an anti-CD3 antibody (Fig. 1b) .
To fulfill the second requirement, cells from skin and blood from the same donors were analysed at the same time, including control PBL which were processed by the isolation procedure used for skin cells. The results obtained (Fig. 2) were compared to those reported using immunocytochemistry on whole skin (8) . In terms of the eight surface markers analyzed, PBL and skin-derived T cells differed in the expression of six. Skin T cells consisted essentially of only memory cells as defined by the CD45RO isotype (mean 94% in five experiments) with a corresponding decrease in CD45RA ϩ naive cells (mean of 6% in two experiments). They contained an increased proportion of cutaneous lymphocyte antigen positive cells (mean of 73% CLA ϩ cells in four experiments), and lymphocytes which expressed the activation markers HLA-DR (mean of 63% in three experiments) and CD25 (mean of 81% in five experiments). These figures matched those previously reported by Bos et al. (8) for lymphocytes in intact skin, suggesting that they have not been modified by the extraction procedure used. The latter was further verified by showing that exposure of PBL to collagenase has not altered the functional activity (to be shown in the next section) nor the FACS profile of PBL with the exception of a reduction of the mean fluorescence intensity of CD4, which was matched by the CD4 pattern of T cells in the skin (Fig. 3) . Because of its selective nature, we do not attribute the reduction of CD4 expression to proteolysis by the neutral proteases present in the collagenase preparation, but rather to a singular vulnerability of the CD4 molecule (31-33). A novel observation reported herein is the marked reduction in the expression of CD49d (VLA-α 4 integrin) among skinderived T cells as compared to PBL, both in terms of percent incidence (mean of 33% in 10 experiments), and fluorescence intensity (Fig. 2) , with little change in other VLA-α chains (data not shown). The CD29 (β 1 integrin) was expressed in essentially all CD3 ϩ skin cells as in PBL, but in one symmetrical peak rather than in two. These results provide an intriguing parallel to those reported by MacKay et al. (34) . These authors detected VLA-α 4 -T lymphocytes solely in afferent lymph from skin.
Functional assays
Since the ability to proliferate is an essentially universal property of all mature lymphocytes, we chose this responsiveness for our initial study of the functional properties of skinderived T cells. To our surprise and consternation, these cells failed to proliferate to any and all ligands alone or in combination ( Table 1) . The latter included anti-CD3 antibodies, IL-2, the lectins PHA and Con A, phorbol esters PMA and TPA plus ionomycin. They also failed to proliferate to superantigens and anti-CD2, CD28 and CD5 antibodies as co-stimulators (not shown). There was a marginal response to IL-2; however, even when this was augmented by anti-CD3 antibodies, the responding cells did not expand. It is to be noted that PBL of which 7% or less expressed receptors for IL-2 incorporated more thymidine than skin-derived T cells with an average expression of IL-2 receptor (IL-2R) of 81%.
We do not attribute this lack of reactivity to an effect of the cell purification procedure used, as the response of PBL from the same donors put through the same procedure assayed within the same experiments was not significantly affected. Nor was it due to a loss of viability as verified by cell counting. In fact, cultures of PBL and skin-derived T cells were indistinguishable after 24 h exposure to PHA when both sets formed clumps and appeared to increase in size. Altered kinetics were excluded as proliferation of skin-derived T cells was not detected at any time up to 1 week of culture. We excluded any putative anti-proliferative activity in these cell preparations, as addition of unpurified skin cells did not interfere with the proliferative activity of autochtonous PBL (not shown). The lack of reactivity was not a function of APC, as addition of irradiated autochtonous PBMC or skin-derived dendritic cells had no influence on the response (Fig. 4) .
Since the majority of skin-derived T cells are CLA ϩ and are likely derived from the CLA ϩ subset present in the circulation (17) , it was conceivable that such cells may have been devoid of proliferative capacity regardless of their source. We excluded this possibility by finding the proliferative reaction of CLA ϩ cells isolated from blood to be normal (results not shown). Proliferation of lymphocytes in response to agonists requires the mobilization of calcium ions which can be brought about by Ca 2ϩ ionophores. To corroborate the lack of proliferative activity of skin T cells and to examine its cause, experiments were carried out to measure Ca 2ϩ flux in skin T cells and PBL in response to PHA. The skin T cells used were freshly prepared, were fully viable and, like PBL, could mobilize Ca 2ϩ ions in response to ionomycin attesting to their patency. However, the very same cells showed a reduced Ca 2ϩ flux relative to PBL in response to PHA (Fig. 5) . Accordingly, this observation could account, at least in part, for the lack of proliferative activity of skin T cells.
A second major difference in the functional activities of blood and skin-derived lymphocytes was revealed in their different kinetics of IFN-γ production as detected by fluorescence microscopy according to the technique of Sander et al. (26) . This group (26, 35, 36) has shown that cells producing cytokines in general (17 of 19 different cytokines) and those producing IFN-γ in particular can be detected and distinguished from those which may have taken up cytokines passively by the localization of de novo synthesized cytokines in the Golgi network. This procedure has been found reliable by all participants of a recent workshop on intracellular staining of lymphokines (37) . This staining pattern was seen in the present investigation in both PBL and skin-derived T cells activated to synthesize IFN-γ (Fig. 6 ). The main difference between the lymphocytes from the two sources was that, whereas in PBL intracytoplasmic IFN-γ was first detected after 42 h of activation, in skin T cells synthesis was found within 2.5 h. Whereas synthesis within PBL was sustained for 3 days, which was the longest time interval tested, in skin T cells the duration was for Ͻ90 min, i.e. it was no longer detectable 4 h after activation.
Cytokine production detected by intracellular fluorescence in PBL has been confirmed by subsequent accumulation of the cytokine in culture supernatants by Radboud et al. (36) . Similarly, we have also detected IFN-γ in culture supernatants from activated PBL, but we failed to do so in supernatants from activated skin T cells. We attribute this failure to the much shorter time of synthesis by skin T cells as compared to PBL and hence their lesser accumulation in the culture supernatant. However, the latter as measured by ELISA in culture supernatants in vitro is an arbitrary amount, which may greatly exceed what may be an effective lymphokine concentration in the vicinity of secreting cells in a given microenvironment in vivo (38) . A summary of the results obtained testing IFN-γ synthesis is shown in Table 2 . The percentage of IFN-γ ϩ cells was comparable between experiments, and between skin and PBL, regardless whether PHA ϩ IL-12 or anti-CD3 ϩ IL-2 was used for activation. This percentage was much lower in response to a mixture of environmental antigens (purified protein derivative, mumps, streptodornase-streptokinase) used together with IL-2, IL-12 or both. No IFN-γ-containing cells whatever were detected in response to the 2 cytokines alone, or in control preparations using PHA ϩ IL-12, but substituting normal IgG1 for the anti-IFN-γ mAb D9D10. Simultaneous staining for intracellular and cell surface fluorescence in four experiments revealed that an average of 85 Ϯ 5% of the IFN-γ-containing cells from skin could be accounted for as CD3 ϩ T cells (Fig. 6c) . Among these cells 62 Ϯ 8% were CD4 ϩ and 26 Ϯ 4% were CD8 ϩ (Fig. 7) . The corresponding numbers for PBL were 68 and 32% respectively (results not shown). Chan et al. have previously shown that secretion of IFN-γ by PBL required APC from blood other than monocytes or B cells, which were not effective (39) . They also demonstrated a requirement for IL-12. Experiments carried out in the present investigation found identical requirements for T cells isolated from skin. Thus irradiated PBMC or dendritic cells prepared from skin dermis or epidermis could each be used with either skin or blood-derived lymphocytes equally well (Fig. 8) ; monocytes from blood were not effective. Accordingly, the difference in the kinetics of IFN-γ production between skinderived lymphocytes and PBL cannot be attributed to APC function.
As noted above, IL-12 used in conjunction with PHA, and IL-2 together with anti-CD3 antibodies each induced comparable numbers of IFN-γ-producing cells. To probe the role played by these cytokines, inhibition experiments using anti-IL-2 and anti-IL-12 were carried out (Fig. 9) . As expected, anti-IL-2 reduced the number of IFN-γ ϩ cells in cultures activated in the presence of IL-2 and anti-IL-12 inhibited the response by neutralizing the IL-12 added. However, whereas anti-IL-12 was also inhibitory in cultures initiated with anti-CD3 ϩ IL-2, anti-IL-2 did not interfere with the reaction elicited by PHA ϩ IL-12. These observations suggest that IL-12 may be an obligatory stimulant in this system and that IL-2 may be effective via induction of IL-12.
All the foregoing experiments showing an accelerated production of IFN-γ by skin-derived T cells were carried out using cells in suspension, which have been incubated in collagenase overnight. To ascertain that the results obtained were not an artefact of this preparative procedure, two types of experiments were carried out. In the first, PBL processed by the same procedure as skin cells showed no change in their tempo of IFN-γ synthesis. In the second approach, fresh pieces of intact skin were injected intradermally and then placed in organ culture for either 2.5 or 4 h, when they were snap-frozen and sections cut were stained with anti-IFNantibody. Cells with the typical pattern of intracellular IFN-γ localization as seen in PBL or skin cell suspensions (Fig. 6) were detected in skin injected with PHA ϩ IL-12, but not with control medium, in skin cultured for 2.5 h, but not in those cultured for 4 h (Fig. 10) . This experiment was repeated twice more with skin from different donors yielding identical results: thus cells with intracellular IFN-γ were identified in every section and in most fields from skin injected with PHA ϩ IL-12 2.5 h earlier. Such cells were never seen in any of the control specimens. Accordingly the fast tempo of IFN-γ production and its short duration detected in suspensions of skin-derived lymphocytes was confirmed to occur in intact skin.
Regulation of IFN-γ synthesis in T cells from skin
The production of IFN-γ, as that of most cytokines, is tightly regulated primarily at the level of transcription (40) . mRNA for cytokines have short half-lives of the order of Ͻ2 h (41) and are normally not detected in resting cells. As shown in Fig. 11(a) , lymphocytes isolated from blood have no detectable IFN-γ mRNA as analyzed by RT-PCR through 45 cycles of amplification. In great contrast, an identical analysis performed on freshly isolated skin T cells revealed IFN-γ mRNA which persisted in these cells through 30 h of culture without deliberate stimulation (Fig. 11b) . Since this mRNA was also detected in freshly excised unmanipulated facial skin, as well as in RNA prepared from freshly frozen biopsies of skin from the arm of healthy volunteers, it is unlikely that it was induced either by the operative procedure or during cell purification.
To determine whether the continued presence of this mRNA in cultured cells was due to on-going synthesis, skin T cells were cultured in the presence or absence of the RNA synthesis inhibitor actinomycin D. Whereas RNA extracted from skin cells cultured without actinomycin D showed a cDNA band of the expected molecular size following amplification with All skin preparations were analyzed 2.5 h following T cell activation; all PBMC were evaluated after 42 h of culture. In experiments using PHA ϩ IL-12 or CD3 ϩ IL-2 for stimulation, the total number of cells counted was ജ500. For the two experiments (A and B) using antigens for activation the number of cells containing IFN-γ per total number of cells counted are shown. The antigens used were a mixture of mumps (12.5 µg/ml), streptodornase-streptokinase (12.5 µg/ml) and purified protein derivatives (10 µg/ml).
Fig. 7.
The proportion of CD3 ϩ , CD4 ϩ and CD8 ϩ lymphocytes among IFN-γ-producing skin cells. Simultaneous staining for intracellular IFN-γ and cell surface T cell markers in four experiments showed that 85% were CD3 ϩ , 62% CD4 ϩ and 26% CD8 ϩ .
primers for IFN-γ in RT-PCR, this band was absent from the same donor's cells cultured in the presence of the inhibitor (Fig. 12) . mRNA for β-actin was present in both RNA preparations, but disappeared after a longer exposure to actinomycin D compatible with its longer half-life. According to the foregoing, mRNA for IFN-γ present in unactivated skin cells persists undiminished for at least 30 h. The results obtained using actinomycin D suggest that this persistent presence is due to ongoing RNA synthesis.
As has been shown in Fig. 6(b) , IFN-γ synthesis in skin T cells is induced 2.5 h following activation. When IFN-γ mRNA levels in these cells were examined and compared to that in unactivated cells, no increase was seen at any time after activation; in fact following 4 h of activation mRNA for IFN-γ, but not for β-actin became undetectable (Fig. 13a) , this time point corresponding with the cessation of IFN-γ synthesis. In contrast, similar activation of PBL, which do not initially express detectable levels of IFN-γ mRNA, triggered mRNA synthesis. The apparent shutdown of IFN-γ mRNA synthesis in activated skin T cells was selective. As shown in Fig. 13(b and c) , transcription of IL-2, which is also seen in (Table 2) . unstimulated skin T cells, was not diminished by activation with PHA ϩ IL-12 nor was the transcription of CD25 mRNA affected.
Discussion
During the initial phases of this investigation we have been much concerned about the possibility that the lymphocytes we prepared from skin might be no more than PBL in disguise, Fig. 9 . IL-12 is essential for IFN-γ production by both PBL and skin T cells. Lymphocytes were activated with either PHA ϩ IL-12 (nos 1-3) or anti-CD3 ϩ IL-2 ( nos 4-6). Anti-IL-2 was added to cultures nos 2 and 5 and anti-IL-12 to nos 3 and 6. Whereas anti-IL-2 only inhibited IFN-γ production in cell cultures activated by IL-2, anti-IL-12 inhibited it when the cells were activated with either IL-12 or IL-2. All the differences shown, except that between combinations 1 and 2, are statistically significant. present as contaminant. However, through each new series of experiments which revealed an increasing array of major differences in the physiology between PBL and skin-derived lymphocytes, we consider now this possibility remote and the question itself to be without meaning.
Among the differences which separate skin T cells and PBL, IFN-γ appears to be central and as such the question whether within the skin we can attribute IFN-γ production entirely to the lymphocytes may need to be considered. Three lines of indirect evidence can be cited to support the affirmative. Thus at least 85% of skin cells with detectable intracellular IFN-γ were shown to be CD3 ϩ cells, hence presumably T lymphocytes (Fig. 7) . The overwhelming, if not exclusive role of T cells in IFN-γ production in the skin is reinforced by the fact that an anti-CD3 mAb in concert with IL-2 could induce maximal IFN-γ production, matching the number of skin cells turned on by IL-12 ϩ PHA (Table 2 ). In the third instance, the same conclusion is born out by evidence of a different kind. Thus IFN-γ production assessed as mRNA expression for IFN-γ in the skin was not detectable in anergic patients with a selective deficit in skin T cells (24) : putative IFN-γ-producing cells other than lymphocytes ought to show mRNA for IFN-γ in these patients. However, given that all the foregoing represents indirect evidence, verification of this conclusion would require direct experiments.
The first novel observation reported in this communication is the ability of T cells present in human skin to respond to activation in situ. This finding demonstrated that lymphocytes can be activated outside organized lymphoid tissue as originally proposed by the concept of 'peripheral sensitization' (1, 42) . Equally important are two features of this response, which to our knowledge have not been previously reported, i.e. that this activation is manifested by IFN-γ synthesis divorced from cell proliferation and with a tempo unmatched by lymphocytes from any other source. We are confident that these kinetics are not an artefact of the isolation procedure used, as IFN-γ synthesis of PBL was not modified by exposure to collagenase under the same conditions. Most importantly, we also detected IFN-γ synthesizing cells in intact skin after the same time interval, i.e. 2.5 h following activation. Using freshly excised pieces of skin in the latter experiments allowed us also to ascertain that the responding cells were present in the skin and were not recruited to the skin site during the 2.5 h of activation. It should also be pointed out that this observation is not exclusive to facial skin which was used throughout this investigation, as identical results were also obtained using breast skin.
The second important observation described in this communication shows that the regulation of IFN-γ synthesis in skin-derived T cells differs from its regulation in PBL in several important aspects which might be responsible for its unique reaction pattern. First, mRNA is expressed in the former without deliberate stimulation, not likely to have been induced during the operative procedure, collection of the skin specimen or the subsequent isolation of lymphocytes. This has been ascertained by the detection of IFN-γ mRNA in extracts of freshly frozen skin biopsies taken from the arm of unimmunized, healthy volunteers. These results, coupled with the observation that mRNA for IFN-γ in skin T cells is maintained in a steady state within or outside the skin micro-environment for at least 30 h, suggest that the IFN-γ gene in skin T cells is transcribed in a constitutive manner. It has been widely accepted and shown that lymphokine signals in the immune system are transient, and must be cleared to avoid deleterious chronic stimulation (43) . This requirement is met by the absolute dependence of lymphokine gene transcription on 5) and from blood (lanes 6-10) were activated with PHA ϩ IL-12 for various time intervals, when RNA was extracted, reverse transcribed, and cDNA for IFN-γ and β-actin analyzed by PCR. Whereas mRNA for IFN-γ decreased in skin samples with increasing time of activation (0 h, 1.5 h and 4 h shown in lanes 1, 3 and 5 respectively, mRNA for β-actin from the same samples remained essentially unchanged (lanes 2, 4 and 6). In blood cells mRNA for IFN-γ (lane 7) but not for β-actin (lane 8) was undetectable without activation; both were present 24 h after activation (lane 9 for IFN-γ and 10 for β-actin). All cultures (except those at time 0) contained 10 µg/ml PHA and 10 U/ml IL-12. lymphocyte activation, which declines within a finite period of time. In the case of skin T cells, activation is also essential for IFN-γ production, but unlike in other lymphocytes it does not rely on induction of transcription, but can initiate translation from existing mRNA directly. The difference between the two modes is time: IFN-γ from PBL is secreted 42 h following activation, whereas that from skin T cells it is available 17 times faster. These observations suggest a critical involvement of a translational control mechanism in the regulation of IFN-γ synthesis in skin T cells, not seen in other lymphocytes.
Another unique feature of IFN-γ regulation in skin T cells is a decrease in the mRNA steady state following activation. Although this decrease could be due to an increased rate of RNA degradation and/or to a cessation of synthesis, we prefer the latter interpretation for two reasons. The similarity of the decline in mRNA following activation and that induced by actinomycin D is striking. The second reason for our preference is the observed selectivity of the down-regulation of IFN-γ mRNA upon activation as compared to that of IL-2 and IL-2R (Fig. 13b and c) . This observation lends credence to the view that this is a regulated event, which in the case of most cytokines is predominantly achieved transcriptionally. According to this interpretation, two functions can be assigned to skin T cell activation, i.e. to induce IFN-γ translation and to stop IFN-γ mRNA transcription. It follows from this scheme that IFN-γ production in skin T cells can be fully ascribed to mRNA synthesized prior to activation. This conclusion is also born out by the observation that whereas addition of actinomycin D together with PHA ϩ IL-12 prevented the synthesis of IFN-γ by PBL, the same protocol allowed IFN-γ production by skin T cells (results not shown). Based on these observations, it appears that skin T lymphocytes are preprogrammed to synthesize IFN-γ both in terms of the amount made and the time frame of synthesis. This mechanism represents a second translational control of IFN-γ synthesis of a kind which has not been previously described. We found these characteristics remarkably constant throughout numerous experiments, regardless of the stimulus.
The unique features of skin-derived T cells discussed above raise the question of their identity or derivation. The high level of expression of CLA on skin-derived T cells (18) , itself a ligand for E-selectin in skin (21, 22) , and the accumulation of CLA ϩ cells at DTH reaction sites (19) is suggestive of a link between CLA ϩ cells in blood and skin. A second link between these cells is their unique ability to produce IFN-γ upon stimulation. We found and will report elsewhere that IFN-γ synthesis by T cells in blood is a property confined to CLA ϩ cells (submitted). Whereas these common properties are compatible with an identity between CLA ϩ cells in blood and skin recirculating between these tissues as proposed by Picker et al. (19) , the unique features of skin-derived T cells suggest an alternative explanation: It is conceivable that skin T cells derived from CLA ϩ precursors in blood may differentiate in skin to give rise to a distinct skin-resident subset.
We did consider the possibility that the T cells we identified in skin may be activated cells through previous exposure to antigen in skin: this would be compatible with their high level of expression of HLA-DR and IL-2R, which are thought to be markers of T cell activation. If so, they might fail to proliferate and synthesize IFN-γ mRNA due to a transient refractory period induced by the initial activation. To test this possibility we activated PBL in primary and secondary mixed lymphocyte reaction, and monitored their proliferative activity and IFN-γ production throughout: at no time could we find a reaction pattern as encountered among skin-derived T cells. Furthermore, activated cells such as PHA blasts have been shown to respond to further stimulation by accelerated and increased IFN-γ gene transcription (39) , unlike skin T cells where activation turns off an ongoing transcription. Finally, skin T cells are indeed not refractory to stimulation, which elicits IFN-γ synthesis, but rather it is the mode of response which is different from that of PBL and may be unique to skin T cells.
According to the foregoing, we prefer the interpretation that CLA ϩ T cells which home to the skin undergo changes there not through antigenic stimulation, but differentiation under the influence of the skin microenvironment. We envisage this to occur in one of two ways. These changes in T cells may be actively promoted and maintained while in the skin, the cells reverting to a 'resting state' as in blood upon leaving the skin. Such a model would be compatible with their recirculation between skin and blood. Alternatively the changes occurring in the skin could represent a terminal differentiation event giving rise to a distinct subset of T cells no longer able to proliferate, but preprogrammed for a quick short burst of IFN-γ synthesis upon stimulation. If true, this alternative would represent a precursor-to-product relationship in a one-way traffic from blood to skin. Since direct evidence on lymphocyte recirculation in humans is difficult to obtain, the choice between the two models hinges on the question whether the distinct functional and phenotypic characteristics of T cells from the skin are permanent or lasting only while the cells are in the skin. In terms of IFN-γ mRNA we documented its persistence in isolated lymphocytes for at least 30 h which represents no less than 15 half-lives. During this time the mRNA concentration would have been reduced by a factor of 30,000 in the absence of continued transcription. Based on this observation, with a caveat that the skin T cell preparations used did contain a residue of other than T cells which could have modified their IFN-γ gene transcription, we would favor the second alternative.
Regardless of the fate of the cells after leaving the skin, if indeed they do so, their properties while in the skin do suggest a function. In the context of human skin we think of these T cells as being the antigen-specific component of a first line host defence system. We consider three attributes of these cells important for their proposed function, i.e. the rapidity of the IFN-γ response, its divorce from cell proliferation and its preprogrammed limited availability. The rapid induction of the response may be critical to cope with microbial challenges through skin. This tempo, which is not a feature of cognate immune mechanisms, may be one of its earliest manifestations, approaching that of natural immune mechanisms. IFN-γ may be particularly suited to fulfil this function. This lymphokine has been shown to synergize with the inflammatory cytokines IL-1 and tumor necrosis factor-α (44), for which mRNA are transcribed in resting human skin (26) , and which are essential for the up-regulation of LFA-1 and ICAM-1 to allow leukocyte traffic into the skin (45) . At least in rats, injection of an anti-IFN-γ antibody has been shown to prevent leukocyte entry into the skin (46) as well as the development of a cutaneous DTH reaction (47) . These results are compatible with the notion that such IFN-γ would be locally produced in the skin. Indirect evidence obtained in our own laboratory in a group of patients which showed a correlation between a lack of detectable T cells in skin and inability to mount a DTH reaction is also compatible with this interpretation. It is also to be noted that IL-12, which is essential for IFN-γ production (39 and this report), has been detected in uninjected human skin, as well as mRNA for IL-12 (50) . IFN-γ in turn has been shown to potentiate IL-12 production in Langerhans cells (49) . Furthermore, IL-12 is induced preferentially by mycobacteria, which are the most frequent and potent antigens to induce DTH. The second attribute of skin T cells, i.e. their inability to proliferate, may be important to limit immune responses in the skin which is so richly endowed with professional antigenpresenting cells and keratinocytes as source of cytokines to promote them. The preprogrammed restriction of the availability of IFN-γ may subserve the same function, which may be important in view of the exquisite sensitivity of skin to this cytokine (50) . In the light of the results presented in this communication, we would like to propose that T cells present in unchallenged human skin fulfil a unique function, acting as the antigen-specific component of a skin-based, first-line host defense system.
